Quantbot Technologies LP raised its stake in shares of Intrexon Corporation (NYSE:XON) by 423.7% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 9,993 shares of the biotechnology company’s stock after acquiring an additional 8,085 shares during the period. Quantbot Technologies LP’s holdings in Intrexon were worth $189,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Synovus Financial Corp raised its stake in Intrexon by 0.6% during the 2nd quarter. Synovus Financial Corp now owns 33,613 shares of the biotechnology company’s stock valued at $810,000 after acquiring an additional 200 shares during the last quarter. Alliancebernstein L.P. raised its stake in Intrexon by 0.6% during the 2nd quarter. Alliancebernstein L.P. now owns 32,610 shares of the biotechnology company’s stock valued at $786,000 after acquiring an additional 200 shares during the last quarter. Legal & General Group Plc raised its stake in Intrexon by 2.1% during the 2nd quarter. Legal & General Group Plc now owns 18,843 shares of the biotechnology company’s stock valued at $454,000 after acquiring an additional 393 shares during the last quarter. National Planning Corp raised its stake in Intrexon by 13.4% during the 2nd quarter. National Planning Corp now owns 12,958 shares of the biotechnology company’s stock valued at $316,000 after acquiring an additional 1,528 shares during the last quarter. Finally, State Board of Administration of Florida Retirement System raised its stake in Intrexon by 2.1% during the 2nd quarter. State Board of Administration of Florida Retirement System now owns 77,176 shares of the biotechnology company’s stock valued at $1,859,000 after acquiring an additional 1,570 shares during the last quarter. 77.39% of the stock is owned by hedge funds and other institutional investors.

Several research firms have commented on XON. Northland Securities set a $30.00 price objective on Intrexon and gave the company a “buy” rating in a research note on Monday, August 7th. BidaskClub cut Intrexon from a “hold” rating to a “sell” rating in a research report on Friday, August 4th. JMP Securities reiterated an “outperform” rating and set a $42.00 target price on shares of Intrexon in a research report on Thursday, October 5th. Griffin Securities reiterated a “buy” rating and set a $55.00 target price on shares of Intrexon in a research report on Friday, October 6th. Finally, Bank of America dropped their target price on Intrexon from $25.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, November 10th. Two research analysts have rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $38.50.

Intrexon Corporation (XON) traded down $0.09 on Friday, hitting $13.55. The company had a trading volume of 1,136,265 shares, compared to its average volume of 2,020,708. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.85 and a current ratio of 2.05. Intrexon Corporation has a 1-year low of $10.26 and a 1-year high of $30.96.

COPYRIGHT VIOLATION NOTICE: “Quantbot Technologies LP Has $189,000 Holdings in Intrexon Corporation (XON)” was first posted by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2017/12/02/quantbot-technologies-lp-has-189000-holdings-in-intrexon-corporation-xon.html.

About Intrexon

Intrexon Corporation (Intrexon) forms collaborations to create biologically-based products and processes using synthetic biology. The Company’s domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components.

Institutional Ownership by Quarter for Intrexon (NYSE:XON)

Receive News & Ratings for Intrexon Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon Corporation and related companies with MarketBeat.com's FREE daily email newsletter.